Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures
- 期刊名称Biologics: Targets & Therapy
- 作者Singh, Kern; Ghodadra,
- 电子ISSN1177-5475
- 文件大小400.70KB
- 发表时间2008-09
- DOI10.2147/btt.s3394
Golimumab in unresponsive ulcerative colitisOtt, Claudia; Lippert, Elisabeth; Mueller, Martina · Biologics: Targets and Therapy · 2014
Targeted therapy for sarcomasForscher, Charles; Figlin, Robert; Mita, Monica · Biologics: Targets and Therapy · 2014
Book review: Safety of Biologics TherapyRobak, Tadeusz · Biologics: Targets and Therapy · 2017
ArrayMascarenhas, Desmond; Herndon, David; Arany, Istvan · Biologics: Targets and Therapy · 2017
Clinical use of biologics in vasculitis syndromesParoli, Marino · Biologics: Targets and Therapy · 2012
Ovarian cancer: emerging molecular-targeted therapiesSourbier, Carole · Biologics: Targets and Therapy · 2012
Erythropoiesis stimulating agents approaches to modulate activitySinclair, Angus · Biologics: Targets and Therapy · 2013
OnabotulinumtoxinA in the treatment of neurogenic bladderMangera, Altaf; Gulamhusein, · Biologics: Targets and Therapy · 2012